Skip to main content

Advertisement

Log in

Development of Kaposi’s sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 10 February 2010

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nicoli P, Familiari U, Bosa M, Allice T, Mete F, Morotti A, et al. HHV8-positive HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Int J Hematol. 2009;90:392–6.

    Article  CAS  PubMed  Google Scholar 

  2. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood. 1995;86:1276–80.

    CAS  PubMed  Google Scholar 

  3. Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med. 2000;342:1027–38.

    Article  CAS  PubMed  Google Scholar 

  4. Dham A, Peterson BA. Castleman disease. Curr Opin Hematol. 2007;14:354–9.

    Article  CAS  PubMed  Google Scholar 

  5. Naresh KN, Rice AJ, Bower M. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma. Am J Surg Pathol. 2008;32(7):1006–12.

    Article  PubMed  Google Scholar 

  6. Bower M, Powles T, Williams S, Davis TN, Atkins M, Montoto S, et al. Brief communication: rituximab in HIV-associated multicentric Castleman disease. Ann Intern Med. 2007;147(12):836–9.

    PubMed  Google Scholar 

  7. Oksenhendler E. HIV-associated multicentric Castleman disease. Curr Opin HIV AIDS. 2009;4(1):16–21.

    Article  PubMed  Google Scholar 

  8. Pastor MA, Vasco B, Mosquera JM, Debén G, Bautista P, Requena. Two HHV8-related illnesses in a HIV-negative patient: Kaposi’s sarcoma and multicentric Castleman’s disease. Response to treatment with Rituximab and CHOP. Acta Dermosifiliogr. 2006;97(6):385–90.

  9. Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin I, Viard JP, et al. Rituximab therapy for HIV-associated Castleman disease. Blood. 2003;102(8):2786–8.

    Article  CAS  PubMed  Google Scholar 

  10. Clifford KS, Demierre MF. Progression of classic Kaposi’s sarcoma with rituximab. J Am Acad Dermatol. 2005;53:155–7.

    Article  PubMed  Google Scholar 

  11. Bollen J, Polstra A, Van Der Kuyl A, Weel J, Noorduyn L, Van Oers M, et al. Multicentric Castleman’s disease and Kaposi’s sarcoma in a cyclosporin treated, HIV-1 negative patient: case report. BMC Blood Disord. 2003;3(1):3.

    Article  PubMed  Google Scholar 

  12. Stebbing J, Gazzard B, Newsom-Davis T, Nelson M, Patterson S, Gotch F, et al. Nadir B cell counts are significantly correlated with the risk of Kaposi’s sarcoma. Int J Cancer. 2004;108:473–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Miles Prince.

Additional information

An answer to this letter to the editor is available at doi:10.1007/s12185-010-0498-8.

About this article

Cite this article

Law, A.B., Ryan, G., Lade, S. et al. Development of Kaposi’s sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient. Int J Hematol 91, 347–348 (2010). https://doi.org/10.1007/s12185-010-0497-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-010-0497-9

Keywords

Navigation